Diabetes Series Live

Online Events

Basal Insulin

  • CME
    1.0

    Optimizing Basal Insulin Therapy: Evolving Tools and Treatment Designs

    Speakers:Jason Gaglia, MD, Director of Hood Center for the Prevention of Childhood Diabetes
    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education

    Duration: 60 minutes

    Presented on: February 1, 2017

  • CME
    1.0

    Optimizing Basal Insulin Therapy: Implementation, Management, and Overcoming Barriers

    Speakers:Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education

    Duration: 60 minutes

    Presented on: April 5, 2017

Cardiovascular Disease, Diabetes, and Diabetes Treatments

  • CME
    1.0

    Diabetes and Cardiovascular Disease: What are the Issues?

    Speakers:Donald E. Cutlip, MD, Section Chief, Interventional Cardiology
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: March 1, 2017

  • CME
    1.0

    Cardiovascular Disease and Diabetes Medications: Analyzing the Outcome Studies and Understanding their Implications

    Speakers:Donald E. Cutlip, MD, Section Chief, Interventional Cardiology
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Robert E. Heinig, MD, Director, Vascular Disease Prevention Program
    Vivian A. Fonseca, MD, FRCP, Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Duration: 60 minutes

    Presented on: March 1, 2017

  • CME
    1.0

    Cardiovascular Disease and Diabetes Medications: Applying Trial Outcomes to Clinical Practice

    Speakers:Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Michael Rocco, MD, Medical Director of Stress Testing and Cardiac Rehabilitation
    Stephen A. Brunton, MD, FAAFP, Executive Vice President
    Om P. Ganda, MD, Senior Physician, and Director, Lipid Clinic

    Duration: 60 minutes

    Presented on: March 29, 2017

Joslin Diabetes Grand Rounds - Basal Insulins

  • CME
    1.0

    The Evolution of Basal Insulins: One Small Step or a Giant Leap?

    Speakers:Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Richard Pratley, MD, Medical Director

    Duration: 60 minutes

    Presented on: October 13, 2016

Medication Advancement

  • CME
    1.0

    The Evolving Spectrum of Antidiabetes Medications: Practical Perspectives and Clinical Challenges

    Speakers:Mark E. Molitch, MD, Professor in Medicine-Endocrinology
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education
    Martin J. Abrahamson, MD, Associate Professor of Medicine

    Duration: 60 minutes

    Presented on: October 6, 2016

Speakers

Basal Insulin

  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.

Cardiovascular Disease, Diabetes, and Diabetes Treatments

  • Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Section Chief, Interventional Cardiology

    Donald E. Cutlip, MD, is section chief of interventional cardiology and director of the Cardiac Catheterization Laboratory at Beth Israel Deaconess Medical Center, professor of medicine at Harvard Medical School, and a senior investigator at the Baim Institute for Clinical Research in Boston, Massachusetts. His clinical activities focus on coronary and valvular interventions, with a special interest in cardiovascular disease in patients with diabetes. He is involved in the design and management of numerous clinical trials of coronary, valvular, and peripheral vascular interventions. Dr Cutlip founded the Academic Research Consortium, and was a member of the ACC/AHA Task Force’s writing committee for key data elements and definitions for cardiovascular endpoint events in clinical trials.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.
  • Robert E. Heinig, MD

    Robert E. Heinig, MD

    Robert E. Heinig, MD

    Director, Vascular Disease Prevention Program

    Robert E. Heinig, MD, is clinical professor of medicine at the University of Rochester Medical School and director of the Vascular Diabetes Prevention Program at Rochester General Hospital in Rochester, New York. His current research interests include genetic and disease-related hyperlipidemia, normocholesterolemic dyslipidemia in insulin-resistant patients predisposing to coronary heart disease, and multiple risk factor modification in diabetic and insulin resistant patients with coronary heart disease. He belongs to several professional societies, including the American Diabetes Association, Endocrine Society, the American Society of Nephrology, and the American Association of Clinical Endocrinologists. Dr Heinig earned his MD from the University of Oregon School of Medicine in Portland.
  • Michael Rocco, MD

    Michael Rocco, MD

    Michael Rocco, MD

    Medical Director of Stress Testing and Cardiac Rehabilitation

    Michael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
  • Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Executive Vice President

    Stephen Brunton, MD, FAAFP, is the executive vice president for education for the Primary Care Education Consortium, works in a group practice in Los Angeles, California, and is an adjunct clinical professor in the Department of Pharmacy Practice at Roseman University of Health Sciences in Salt Lake City, Utah. A board-certified family physician with a certificate of added qualifications in geriatrics, he earned his MD at Monash University Medical School in Melbourne, Australia. He is the former president of the California Academy of Family Physicians and the Association of Family Medicine Residency Directors. Dr Brunton has published numerous articles, chapters, and monographs on family medicine and related clinical topics, and serves in editorial capacities for numerous journals.
  • Om P. Ganda, MD

    Om P. Ganda, MD

    Om P. Ganda, MD

    Senior Physician, and Director, Lipid Clinic

Joslin Diabetes Grand Rounds - Basal Insulins

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Medical Director

    Richard E. Pratley, MD, is Medical Director, Education and Research at the Florida Hospital Diabetes Institute, Senior Investigator at the Translational Research Institute for Metabolism and Diabetes, and an adjunct professor at the Sanford Burnham Prebys Medical Discovery Institute at Lake Nona in Orlando. Dr Pratley’s research interests include the prevention of diabetes, improving the care for older persons with diabetes, developing new drugs to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He has written several peer-reviewed articles, is a principal investigator for various trials in diabetes and obesity, and is an editorial board member and ad hoc reviewer for various journals.

Medication Advancement

  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Professor in Medicine-Endocrinology

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.

All Speakers

  • Jason Gaglia, MD

    Jason Gaglia, MD

    Jason Gaglia, MD

    Director of Hood Center for the Prevention of Childhood Diabetes

    Jason Gaglia, MD, MMSc is Director of the Hood Center for Prevention of Childhood Diabetes at Joslin Diabetes Center and an Assistant Professor of Medicine at Harvard Medical School. He is a practicing adult endocrinologist at Joslin Clinic and Harvard Vanguard Medical Associates. Dr. Gaglia’s research interests include endocrine imaging and immunology of diabetes. He was previously a member of the clinical islet transplant team at the National Institute of Health. More recently he has led a team demonstrating noninvasive imaging of inflammation in the pancreas associated with the development of type 1 diabetes. Dr. Gaglia is an active member of the American Association of Clinical Endocrinologists (AACE). He is on the editorial board of Endocrine Practice, the official journal of AACE, and serves on several AACE committees.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.
  • Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Donald E. Cutlip, MD

    Section Chief, Interventional Cardiology

    Donald E. Cutlip, MD, is section chief of interventional cardiology and director of the Cardiac Catheterization Laboratory at Beth Israel Deaconess Medical Center, professor of medicine at Harvard Medical School, and a senior investigator at the Baim Institute for Clinical Research in Boston, Massachusetts. His clinical activities focus on coronary and valvular interventions, with a special interest in cardiovascular disease in patients with diabetes. He is involved in the design and management of numerous clinical trials of coronary, valvular, and peripheral vascular interventions. Dr Cutlip founded the Academic Research Consortium, and was a member of the ACC/AHA Task Force’s writing committee for key data elements and definitions for cardiovascular endpoint events in clinical trials.
  • Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Vivian A. Fonseca, MD, FRCP

    Professor of Medicine and Pharmacology; Chief, Section of Endocrinology

    Vivian A. Fonseca, MD, FRCP, is a professor of medicine and pharmacology, the Tullis-Tulane Alumni Chair in Diabetes, and chief, Section of Endocrinology, at Tulane University Health Sciences Center in New Orleans, Louisiana. His current research interests include the prevention and treatment of diabetic complications and risk factor reduction in cardiovascular disease. Dr Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London) and the American College of Physicians, and is a member of the Endocrine Society, the American Diabetes Association, and the International Diabetes Federation. He serves on numerous national and international committees, and has published more than 200 papers, review articles and book chapters.
  • Robert E. Heinig, MD

    Robert E. Heinig, MD

    Robert E. Heinig, MD

    Director, Vascular Disease Prevention Program

    Robert E. Heinig, MD, is clinical professor of medicine at the University of Rochester Medical School and director of the Vascular Diabetes Prevention Program at Rochester General Hospital in Rochester, New York. His current research interests include genetic and disease-related hyperlipidemia, normocholesterolemic dyslipidemia in insulin-resistant patients predisposing to coronary heart disease, and multiple risk factor modification in diabetic and insulin resistant patients with coronary heart disease. He belongs to several professional societies, including the American Diabetes Association, Endocrine Society, the American Society of Nephrology, and the American Association of Clinical Endocrinologists. Dr Heinig earned his MD from the University of Oregon School of Medicine in Portland.
  • Michael Rocco, MD

    Michael Rocco, MD

    Michael Rocco, MD

    Medical Director of Stress Testing and Cardiac Rehabilitation

    Michael Rocco, MD, is medical director of Cardiac Rehabilitation and Stress Testing, section of preventive cardiology, and a staff physician in the Departments of Cardiovascular Medicine and Molecular and Functional Imaging in the Division of Radiology at Cleveland Clinic in Ohio. His clinical research focuses primarily on the prognostic significance of asymptomatic ischemia, the evaluation of therapeutic interventions and exercise in the treatment and prevention of coronary artery disease, and the effect of drug therapy on lowering lipid levels. Dr Rocco lectures regionally and nationally, has published articles and abstracts in leading medical journals, and has authored chapters in textbooks. He received his medical degree from Duke University Medical Center in Durham, North Carolina.
  • Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Stephen A. Brunton, MD, FAAFP

    Executive Vice President

    Stephen Brunton, MD, FAAFP, is the executive vice president for education for the Primary Care Education Consortium, works in a group practice in Los Angeles, California, and is an adjunct clinical professor in the Department of Pharmacy Practice at Roseman University of Health Sciences in Salt Lake City, Utah. A board-certified family physician with a certificate of added qualifications in geriatrics, he earned his MD at Monash University Medical School in Melbourne, Australia. He is the former president of the California Academy of Family Physicians and the Association of Family Medicine Residency Directors. Dr Brunton has published numerous articles, chapters, and monographs on family medicine and related clinical topics, and serves in editorial capacities for numerous journals.
  • Om P. Ganda, MD

    Om P. Ganda, MD

    Om P. Ganda, MD

    Senior Physician, and Director, Lipid Clinic

  • Richard Pratley, MD

    Richard Pratley, MD

    Richard Pratley, MD

    Medical Director

    Richard E. Pratley, MD, is Medical Director, Education and Research at the Florida Hospital Diabetes Institute, Senior Investigator at the Translational Research Institute for Metabolism and Diabetes, and an adjunct professor at the Sanford Burnham Prebys Medical Discovery Institute at Lake Nona in Orlando. Dr Pratley’s research interests include the prevention of diabetes, improving the care for older persons with diabetes, developing new drugs to treat and prevent diabetes and its complications, and understanding the role of the fat cell in increasing the risk of diabetes and heart disease. He has written several peer-reviewed articles, is a principal investigator for various trials in diabetes and obesity, and is an editorial board member and ad hoc reviewer for various journals.
  • Mark E. Molitch, MD

    Mark E. Molitch, MD

    Mark E. Molitch, MD

    Professor in Medicine-Endocrinology

    Mark Molitch, M.D. is the Martha Leland Sherwin Professor of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine at the Northwestern University Feinberg School of Medicine. Prior to coming to Northwestern in 1984, Dr. Molitch was an Associate Professor at Tufts University School of Medicine in Boston, Massachusetts. Dr. Molitch has participated in clinical research for many years, focusing on diabetic kidney disease and other long-term complications of diabetes. He has been the PI for the Northwestern center of the Diabetes Control and Complications Trial (DCCT) and its follow-up study, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, the Northwestern Center of the ongoing Diabetes Prevention Program Observational Study (DPPOS), the Northwestern center of the ongoing Prevention of Early Renal Loss (PERL) study in patients with type 1 diabetes, and was the Co-Principal Investigator for Northwestern center of Diabetes of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D). He has also had a long-standing interest in the pathogenesis and treatment of pituitary tumors. Dr. Molitch has been active in the American Diabetes Association (ADA). He chaired the Professional Practice Committee that wrote the 2002 ADA”Standards of Medical Care for Patients with Diabetes Mellitus,” chaired the working group that wrote the ADA Position Statement “Diabetic Nephropathy,” and served as chair of the ADA’s Provider Recognition Program. He also chaired the Technical Expert Review Panel of the National Diabetes Quality Improvement Alliance. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 450 original papers, review articles, book chapters, case reports and other publications. In 1997, Dr. Molitch was the recipient of the “Outstanding Physician Educator in the Field of Diabetes Award” by the American Diabetes Association and in 2013 was the recipient of the “Distinguished Educator Award” of The Endocrine Society. In 2006 he was elected to the Council of The Endocrine Society. He also completed a 3 year term as Chair of the Clinical Endocrinology Update Program of the Endocrine Society in 2012 and was President of the Pituitary Society in 2012-2013.
  • Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Martin J. Abrahamson, MD

    Associate Professor of Medicine

    Dr. Abrahamson is Associate Professor of Medicine at Harvard Medical School and Medical Director at the Joslin Diabetes Center in Boston, Massachusetts. He co-directs the Joslin – Beth Israel Deaconess Medical Center (BIDMC) Diabetes-Heart Program, a joint venture between Joslin Clinic and the Division of Cardiology at BIDMC. At Beth Israel Deaconess Medical Center, Dr. Abrahamson also serves as Director of the Division of Continuing Medical Education in the Department of Medicine. At Joslin Clinic, Dr. Abrahamson is credited with reorganizing the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists. He is spearheading “pathways of care” for patients referred to Joslin (JoslinCare), has co-authored guidelines for both the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies, and has authored more than 50 papers, review articles and chapters related to diabetes. He received his medical degree from University of Cape Town in Cape Town, South Africa, and completed his internship and residency in internal medicine and endocrinology at Groote Schuur Hospital, also in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital. Dr. Abrahamson was joint head of the endocrine unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. Dr. Abrahamson’s research interests include evaluation of the efficacy and utility of a continuous glucose monitoring sensors in the management of patients with diabetes, and prevalence of silent coronary ischemia in patients with diabetes. Dr. Abrahamson is board certified in internal medicine and in endocrinology, diabetes and metabolism, and is a Fellow of the College of Physicians of South Africa.

Partners

Academic

Associations